Abstract
Advances in molecular biology and biochemistry have dramatically increased our understanding of disease. The molecular mechanisms are the pathogenic basis of disease is changing modern medicine. New drugs often inhibit specific key pathways. In nuclear medicine, molecular imaging agents have been used for years, but most contrast agents for MRI or CT today are unspecific. The diagnosis is based on alterations in morphology and basic physiology, all of which are late manifestations of the original molecular changes. There are only few more specific contrast agents available. Microbubbles are the one, of size of blood cells are used as contrast agents for ultrasound imaging and are particularly valuable for targeting selected tissues and for providing useful information about the efficacy of chemotherapy. The exploitation of microbubble agents can be achieved when there is a full understanding of the bubble/ultrasound interaction for microbubbles freely suspended in blood or attached to blood vessel walls. Microbubbles are promising tool for targeting chemotherapeutics, polypeptides and genetic material to its target in body.
Keywords: Microbubble, ultrasound contrast agent, molecular imaging
Current Pharmaceutical Biotechnology
Title: Microbubble: A Potential Ultrasound Tool in Molecular Imaging
Volume: 9 Issue: 5
Author(s): Rajesh M. Patel
Affiliation:
Keywords: Microbubble, ultrasound contrast agent, molecular imaging
Abstract: Advances in molecular biology and biochemistry have dramatically increased our understanding of disease. The molecular mechanisms are the pathogenic basis of disease is changing modern medicine. New drugs often inhibit specific key pathways. In nuclear medicine, molecular imaging agents have been used for years, but most contrast agents for MRI or CT today are unspecific. The diagnosis is based on alterations in morphology and basic physiology, all of which are late manifestations of the original molecular changes. There are only few more specific contrast agents available. Microbubbles are the one, of size of blood cells are used as contrast agents for ultrasound imaging and are particularly valuable for targeting selected tissues and for providing useful information about the efficacy of chemotherapy. The exploitation of microbubble agents can be achieved when there is a full understanding of the bubble/ultrasound interaction for microbubbles freely suspended in blood or attached to blood vessel walls. Microbubbles are promising tool for targeting chemotherapeutics, polypeptides and genetic material to its target in body.
Export Options
About this article
Cite this article as:
Patel M. Rajesh, Microbubble: A Potential Ultrasound Tool in Molecular Imaging, Current Pharmaceutical Biotechnology 2008; 9 (5) . https://dx.doi.org/10.2174/138920108785915175
DOI https://dx.doi.org/10.2174/138920108785915175 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair
CNS & Neurological Disorders - Drug Targets Pediatrics for Disability: A Comprehensive Approach to Children with Syndromic Psychomotor Delay
Current Pediatric Reviews Transcriptional Control of Collagen I Gene Expression
Cardiovascular & Hematological Disorders-Drug Targets Natural Phenolic Compounds as Cardiovascular Therapeutics: Potential Role of their Antiinflammatory Effects
Current Vascular Pharmacology Treatment of Luteal Phase Defects in Assisted Reproduction
Current Drug Targets Mast Cell Chymase and Tryptase as Targets for Cardiovascular and Metabolic Diseases
Current Pharmaceutical Design Current Understanding of In-stent Restenosis and the Potential Benefit of Drug Eluting Stents
Current Drug Targets - Cardiovascular & Hematological Disorders Functional Renal MRI
Current Medical Imaging Structure and Function in COPD
Current Respiratory Medicine Reviews Chronic Tendon Pain: No Signs of Chemical Inflammation but High Concentrations of the Neurotransmitter Glutamate. Implications for Treatment?
Current Drug Targets Chagas Disease Chemotherapy: What Do We Know So Far?
Current Pharmaceutical Design In vivo Optical Molecular Imaging of Cardiovascular Diseases: Long Road Ahead
Current Molecular Imaging (Discontinued) Prasugrel: A Novel Antiplatelet Therapy for Acute Coronary Syndromes
Recent Patents on Cardiovascular Drug Discovery Nutrapharmacology of Tocotrienols for Metabolic Syndrome
Current Pharmaceutical Design Editorial: Bivalirudin and the Matrix Trial: The End of the Story?
Current Vascular Pharmacology Inflammaging and Proteases in Abdominal Aortic Aneurysm
Current Vascular Pharmacology Statins: A Valuable Tool for the Prevention/Regression of Abdominal Aortic Aneurysms
Vascular Disease Prevention (Discontinued) New Foods, New Consumers: Innovation in Food Product Development
Current Nutrition & Food Science MicroRNAs as Early Biomarkers in Obesity and Related Metabolic and Cardiovascular Diseases
Current Pharmaceutical Design Editorial (Hot Topic: Vascular Remodeling)
Current Vascular Pharmacology